Shalby Hospitals Receives Five-Year Approval for Kidney Transplant Services in Ahmedabad
Shalby Hospitals, specifically its Krishna unit located in Ahmedabad, Gujarat, has secured approval for Kidney Transplant services. The approval is effective for a period of five years, commencing on April 9, 2026.This institutional milestone enables patients in the surrounding community to access advanced, life-saving transplant services locally. The local availability is expected to reduce the necessity for long-distance travel and associated expenses for patients. Furthermore, the facility enhances the continuity of care by providing comprehensive pre- and post-transplant management all under one roof.
SHALBY Stock Price Movement
On Friday, Shalby Limited shares edged higher to close at ₹153.89, marking a 1.49% gain for the session. The stock saw significant activity across the day, with total trading volume reaching 123,558 shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.